BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 31718319)

  • 1. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor.
    Pinkert S; Westermann D; Wang X; Klingel K; Dörner A; Savvatis K; Grössl T; Krohn S; Tschöpe C; Zeichhardt H; Kotsch K; Weitmann K; Hoffmann W; Schultheiss HP; Spiller OB; Poller W; Fechner H
    Circulation; 2009 Dec; 120(23):2358-66. PubMed ID: 19933937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
    Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
    J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
    Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
    J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model.
    Lim BK; Yun SH; Ju ES; Kim BK; Lee YJ; Yoo DK; Kim YC; Jeon ES
    Virus Res; 2015 Mar; 199():1-8. PubMed ID: 25485472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
    Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
    J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
    Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
    Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
    Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
    Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
    J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.
    Tschöpe C; Van Linthout S; Jäger S; Arndt R; Trippel T; Müller I; Elsanhoury A; Rutschow S; Anker SD; Schultheiss HP; Pauschinger M; Spillmann F; Pappritz K
    ESC Heart Fail; 2020 Oct; 7(5):2838-2852. PubMed ID: 32662949
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.
    Miteva K; Haag M; Peng J; Savvatis K; Becher PM; Seifert M; Warstat K; Westermann D; Ringe J; Sittinger M; Schultheiss HP; Tschöpe C; Van Linthout S
    PLoS One; 2011; 6(12):e28513. PubMed ID: 22174827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
    Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
    J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
    Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
    Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
    Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
    Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.